A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects bone metastases in patients ...
Jun 7, 2016
0
2
Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the ...
Apr 12, 2016
0
0
Radiofrequency ablation (RFA), a procedure to treat liver metastases in patients with colorectal cancer, was found to induce antitumor immune responses in human samples of primary colon tumor, and mice treated with a combination ...
Mar 1, 2016
0
31
Metastatic prostate cancer, where better therapeutic strategies are desperately needed, appears to be tailor-made for precision oncology, according to a new study by researchers at Fred Hutchinson Cancer Research Center in ...
Feb 29, 2016
0
1
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment ...
Feb 15, 2016
0
247
Approx. 4,700 people in Austria fall ill with bowel cancer every year. One to two percent of the victims also sustain brain metastases during the latter stages of the illness. In a joint study with the University of Southern ...
Feb 1, 2016
0
1
Non-small cell lung cancer (NSCLC) patients with common epidermal growth factor (EGFR) mutations and brain metastases showed improved progression-free survival (PFS) and response from the EGFR tyrosine kinase inhibitor (TKI) ...
Jan 25, 2016
0
7
(HealthDay)—For patients with advanced renal cell carcinoma, cabozantinib is associated with improved progression-free survival (PFS), with consistent improvement across all patient subgroups, according to a study scheduled ...
Jan 5, 2016
0
1
Results of an ongoing phase 1b clinical trial presented today at the 2015 San Antonio Breast Cancer Symposium show promise of the experimental anti-cancer agent ONT-380 against metastatic HER2+ breast cancer, especially against ...
Dec 9, 2015
0
121
Globally, prostate cancer is the second most common type of cancer and the fifth leading cause of cancer-related death in men.
Dec 9, 2015
0
2
